References:

1. Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19 — Studies Needed. New England Journal of Medicine. 2020;382:1194-1196
2. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv. 2020:2020.2002.2022.20026500
3. Li Y, Wang M, Zhou Y, Chang J, Xian Y, Mao L, et al. Acute Cerebrovascular Disease Following COVID-19: A Single center, Retrospective, Observational Study (3/3/2020). 2020. Available at http://dx.doi.org/10.2139/ssrn.3550025
4. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020. doi:10.1001/jamacardio.2020.1017
5. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients. Journal of Medical Virology. 2020
6. Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, et al. The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice. bioRxiv. 2020:2020.2002.2007.939389
7. Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by Human Respiratory Coronaviruses. Journal of Virology. 2000;74:8913-8921
8. Faigle R, Butler J, Carhuapoma JR, Johnson B, Zink EK, Shakes T, et al. Safety Trial of LowIntensity Monitoring After Thrombolysis: Optimal Post Tpa-Iv Monitoring in Ischemic STroke (OPTIMIST). The Neurohospitalist. 2020;10:11-15
9. Alasheev AM, Andreev AY, Gonysheva YV, Lagutenko MN, Lutskovich OY, Mamonova AV, et al. A Comparison of Remote and Bedside Assessment of the National Institute of Health Stroke Scale in Acute Stroke Patients. Eur Neurol. 2017;77:267-271
10. Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol. 2008;7:787-795